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Abstract
Background: Esophageal feeding tubes are commonly used to provide enteral nutri-
tion to cats, but their use is associated with adverse effects.
Objectives: To evaluate the complications associated with e-tube placement in cats
and to identify factors predisposing to these complications.
Animals: Cats that had an esophageal feeding tube placed (n = 248).
Methods: This was a retrospective case review in which clinical records were interro-
gated across 2 referral centers to identify records of cats that had esophageal tubes
placed. Clinical data were collected for signalment, clinical indication, method of
placement, time of removal, and any complications. Logistic regression was then
employed to assess the odds of an increase in complications, including infection and
death.
Results: For those cats that survived to discharge, tubes were in place for a median
of 11 days, ranging from 1 to 93days. Complications occurred in 35.8% of the cats,
with the most common being tube dislodgement (14.5%), followed by stoma site
infections (12.1%). Cats receiving glucocorticoids or oncolytic agents (OR=3.91; 95%
CI, 1.14-13.44) and with discharge at the stoma site (OR=159.8; CI, 18.9-1351) were
at an increased odds of developing a stoma site infection, whereas those with a lower
weight (OR=1.33; 95% CI, 1.02-1.75) or (pancreatic [OR=4.33; 95% CI, 1.02-18.47],
neoplastic [OR=15.44; 95% CI, 3.67-65.07], respiratory [OR=19.66; 95% CI,
2.81-137.48], urogenital [OR= 5.78; 95% CI, 1.15-28.99], and infectious diseases
[OR=11.57; 95% CI, 2.27-58.94]) had an increased odds of death. The duration of
time in place and the cat being discharged with the tube in place were not associated
with an increased risk of infection or death.
Abbreviations: BCS, body condition score; CI, confidence interval; cm, centimeter; DSH, domestic shorthair; E. coli, Escherichia coli; E tube, esophagostomy tube; Fr, French gauge; kg, kilogram;
O tube, oesophagostomy tube; OR, odds ratio.
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Conclusions and clinical importance: Owners should be made aware of the potential
risks involved and their predisposing factors.
K E YWORD S
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1 | INTRODUCTION
Anorexia is a common clinical manifestation of illness that can com-
promise clinical outcome and it is often observed as a nonspecific sign
of illness in cats.1 Early and appropriate nutritional support is crucial
for recovery from illness in both human and veterinary medicine.2 This
support addresses the nutrient requirements to assist in recovery,
including but not limited to cellular metabolism, tissue healing, and
immunocompetence.1,3,4
Feeding tubes bypass diseased or traumatized tissues, as well as
removing reliance upon a cat's appetite to meet nutritional demands.
They can also be used to administer medications, provide a natural
route for water delivery in cats that might be susceptible to volume
overload, or both. Continued enteral nutrition maintains enterocyte
health, promotes local immunoglobulin production, ensures effective
gastrointestinal integrity to minimize bacterial translocation, and pro-
motes hepatic and renal blood flow in rodent models.5–7 Early enteral
nutrition has been shown to reduce hospitalization times in dogs with
septic peritonitis.8 Additionally, enteral nutrition is usually more cost
effective than parenteral options.3
Esophageal feeding tubes have numerous benefits in comparison
to other methods of delivering enteral nutrition. They are relatively
easy to place and do not require any specialized equipment.9 The
gauge of the tubes is usually adequate to allow a variety of food types
to be administered, and can also facilitate the administration of medi-
cation. Esophagostomy tubes (e-tubes) are thought to be generally
well tolerated and there is no lower limit as to how long they must
stay in place, in contrast to the minimal time in place necessary for
gastrostomy or jejunostomy tubes. Cats can be discharged home with
e-tubes in place, allowing for a shorter duration of hospitalization than
otherwise possible.8 However, their placement is not an entirely
benign process, with tube dislodgement, stoma site infection, and
trauma of cervical neurovascular structures being possible conse-
quences.10,11 There is also the necessity for general anesthesia to
facilitate tube placement, which might not be possible in critically
ill cats.
There is a paucity of information in both the human and veterinary
literature regarding e-tube placement, with only 1 previous study
describing complications in 46 cats.11 The number of cases in that
study was relatively small and they did not investigate stoma site
infections in detail. As more veterinarians use this technique, it is
important that veterinarians and owners are aware of the care needed
in managing these cats in the home as well as the clinic environment,
the likely duration an e-tube will be in place, and of potential compli-
cations, including their relative frequency of occurrence.
The aim of this study was to identify the nature and prevalence of
complications following e-tube placement, and whether any cat fac-
tors influence this. Our hypothesis was that those cats that were
immunosuppressed, and had tubes in place the longest would be most
susceptible to infection.
2 | MATERIALS AND METHODS
This study was conducted at 2 referral centers in the United Kingdom,
Centers A and B. Clinical records from May 1, 2005, until May
1, 2017, were reviewed in order to identify cats in which an e-tube
had been placed. The following terms were used to search electronic
clinical records: “O tube,” “O-tube,” “E tube,” “E-tube,” “Oesophageal
feeding tube,” “Esophageal feeding tube,” “Oesophagostomy tube,”
“Esophagostomy tube,” and “feeding tube.” Alongside this, clinical bill-
ing records were reviewed for either the e-tube feeding charge, or the
e-tube placement charge.
The criteria for case selection were that placement of an e-tube
had been recorded; the date that this occurred; that complications
were noted; and that the date of removal was recorded. Cases were
excluded if the date of removal (intentionally or otherwise) was not
recorded. Clinical records were reviewed from the first consultation at
the referral institution until the e-tube was removed, including those
in which it was removed following death.
The following details were identified in the cats’ clinical records
for each tube placed: case signalment; body weight; body condition
score (BCS); diagnosis, if achieved; date the e-tube had been placed;
make (ie, manufacturer) and gauge of tube; whether antimicrobials
were being administered at the time of tube placement, if so, which
antimicrobial drug(s) were administered; presence and nature of com-
plications; whether discharge was present at the stoma site and the
date the discharge was identified (the gross character of the discharge
was inconsistently available so was not recorded); whether an infec-
tion was identified at the stoma site and the date the infection was
noted; culture and in vitro antimicrobial sensitivity profile; whether
the cat had a systemic infection present; whether the cat was receiv-
ing either glucocorticoids or oncolytic agents (the dosing and timings
these were started was inconsistently available so not recorded);
whether the cat was discharged from the hospital with the tube in
place; the date the tube was removed and whether removed inten-
tionally or by the cat; and whether the cat was euthanized with the
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tube in place or not. The following data were then calculated: time
from presentation to the referral center to tube placement (days);
number of days from tube placement to discharge being noted around
the stoma site (where applicable); number of days from tube place-
ment to stoma site infection (where applicable); and the number of
days that the tube was left in place.
An e-tube-associated discharge was defined as secretion from the
stoma site, which was culture negative or in which cytology did not
identify intracellular bacteria. Alternatively, for cases that did not have
cytology or culture performed, this was defined as a secretion that
resolved spontaneously without topical or systemic antimicrobial ther-
apy. This was not considered a complication if it was the only finding
identified.
A clinically relevant e-tube infection was defined as signs of stoma
site inflammation, in which bacteria were cultured, or in which intra-
cellular bacteria were identified on cytology of the discharge or anti-
microbial therapy was necessary to achieve clinical resolution.
Diseases were categorized to allow for exploration of these under-
lying associations with outcomes of interest. The categories of disease
were gastrointestinal, hepatic, pancreatic, traumatic, neoplastic, respi-
ratory, cardiac, urogenital, septic, and infectious. Cats had their dis-
ease categorized as “other” if they did not fit into these categories. If
a cat had more than 1 condition, the condition that was most likely to
be the cause of the presenting clinical signs was used. Survival time
was defined as survival to the last documented time point in the clini-
cal records. If a cat had several e-tubes placed over time, only the first
tube was included, to minimize clustering and artificially skewing
the data.
Data were organized in Microsoft Excel© 2013 version 15 (Micro-
soft Corporation, Redmond, WA, USA), and statistical analyses were
performed using SPSS© Statistics for Windows, version 24.0 (IBM
Corp, Armonk, NY, USA). Incidence over time was evaluated by split-
ting the time of data collection into equal time frames and comparing
with a contingency table. Continuous data were tested for normality by
manual inspection of Q-Q plots and skewness, kurtosis analysis.11,12
Univariate binary logistic regression was performed to assess the
association of variables with outcomes of interest. One of the vari-
ables of interest was death, with potential associated factors including
age, weight, BCS, the presence of systemic inflammation (based on
the final diagnosis and whether this would be expected to cause sys-
temic inflammation, e.g., pancreatitis), presence of systemic infection
(based on the final diagnosis and whether this would be expected to
cause systemic infection, e.g., sepsis), classification of underlying dis-
ease, glucocorticoids or oncolytic agents administered, and institution
where the tube was placed. The other variable of interest was infec-
tion of the stoma site, with the following variables assessed for a rela-
tionship: age, weight, BCS, systemic inflammation presence, systemic
infection presence, glucocorticoids and chemotherapy agents medica-
tions administered, antibiotics administered prior to tube placement,
antibiotics administered after tube placement, number of days the
tube was in place, classification of underlying disease, presence of dis-
charge at the stoma site, tube gauge, make of tube, type of tube, and
institution where the tube was placed. Multivariable binary logistic
regression for each outcome of interest was performed using risk factors
with liberal associations in univariable modeling (P< .2). Multivariable
models were constructed as manual backward stepwise procedures,
using the Hosmer-Lemeshow test and the Omnibus test of model
coefficients, final model variables were examined for correlations and
interactions.
For normally distributed data, comparisons were made using 2-sided
unpaired Student's t-tests. Data not normally distributed were analyzed
using the Mann-Whitney U test. Categorical data were analyzed using
contingency tables, with Chi-squared or Fisher's exact test used for
comparisons. Significance was accepted at P < .05.
3 | RESULTS
3.1 | Population
A total of 880 cats were identified from a clinical record search, of
which 248 cats met the inclusion criteria and were analyzed in the
study; 189 of these were from Center A and 59 from Center B. The
majority of the cats (59.3%) were domestic shorthaired cats, followed
by domestic longhaired (7.7%), British Shorthaired (4.8%), Maine Coon
(4%), and Bengal cats (4%); the remainder were a combination of other
breeds. The age of the cats was normally distributed, with a mean of
7 years 7 months old (SD of 4 years 5 months, range of 6 months to
22 years old). There were 146 male cats, of which 142 were neutered,
and 102 female cats, of which 98 were neutered.
Weight data were available for 237 cats; the data were not nor-
mally distributed, with a median of 4.2 kg (range 1.46-8.3 kg, with
quartiles 3.41 and 5 kg), recording BCS was frequently absent, with
108 cases having scores recorded. The median score was 4 (range of
1-9, with quartiles of 3 and 5).
The underlying conditions for which the cats were presented for are
summarized in Table 1. The infectious diseases diagnosed were 5 cats
with toxoplasmosis, 3 with feline infectious peritonitis, 2 with feline calici
virus infection, and 1 each of feline immunodeficiency virus-associated
disease, salmonellosis, cow pox viral infection, mycobacteriosis, and
Mycoplasma felis infection.
The 29 “other” cases were those in which a diagnosis was not
achieved; the presenting complaint was noted instead, as were the con-
ditions that did not belong to any other category. These included a com-
bination of anorexia, weight loss, anemia, ataxia, pyrexia of unknown
origin, seizures, hemophagocytic syndrome, peripheral vestibular syn-
drome, dysautonomia, hypereosinophilic syndrome, orofacial pain syn-
drome, coagulopathy, primary hyperparathyroidism, tooth root abscess,
necrotic ventral abdominal fat, hypertrophic cardiomyopathy, total ear
canal ablation, peritoneopericardial diaphragmatic hernia, chronic nasal
discharge, tricuspid valve endocarditis, biliary carcinoma, temporoman-
dibular joint dysplasia, and diabetic ketoacidosis.
The glucocorticoids prednisolone, dexamethasone, and budenoside
were administered while the tube was being placed, or was in place.
The chemotherapeutics that were administered were vincristine, cyclo-
phosphamide, doxorubicin, lomustine, and mitoxantrone.
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3.2 | E-tubes description and complications
The majority of the e-tubes were placed either on the day of presen-
tation (63/248, 25.4%) or the following day (79/248, 31.9%). The
most common tube manufacturer was Surgivet (silicone, 75/248,
30%), followed by Mila (polyurethane, 54/248, 21.8%), Cook (polyure-
thane, 20/248, 8.1%), and Portex (polyvinyl chloride, 16/248, 6.5%);
83 cases did not have the tube make recorded. Mila tubes were the
most commonly utilized in the Royal (Dick) School of Veterinary Stud-
ies and Surgivet in Anderson Moores.
The tube size was recorded in 152 cases. The most common tube
sizes were 19Fr (68/152) and 14Fr (66/152), with 14Fr being most
commonly used in the Royal (Dick) School of Veterinary Studies,
whereas in Anderson Moores it was 19Fr.
Of the 162 cats that survived (162/248, 65.3%), the tube was in
place for a median of 11days (range from 1 to 93 days, with quartiles
of 7 and 20days); 78 of these 162 cats (48.1%) experienced a compli-
cation associated with their tube. Of the 86 cats that died (86/248,
34.7%), death occurred at a median of 4 days after presentation
(range 0 to 66days, and quartiles of 2 and 8 days); 11 of these 86 cats
(12.8%) had a complication associated with their e-tube.
Complications associated with having an e-tube in place were
reported in 89 cats (35.9% of all cats). The frequency of complications
is detailed in Table 2. The most common complication was dislodge-
ment of the tube, which occurred due to entire removal by the cat
(17/89, 19.1%), dislodged by the cat necessitating removal (11/89,
12.4%), and dislodged by the cat, followed by re-positioning and re-
suturing (8/89, 9%). No cat had more than 1 complication recorded.
There was no significant difference between complications and when
they were placed within the 12 years of data collection (P= .725).
Infection associated with the tube was the second most common
complication encountered in the study (30/89, 33.7%). An additional
45 cats had a discharge at the stoma site that was self-limiting and did
not necessitate treatment, so was not considered an infection. The
median time to stoma discharge was 6 days (range 1 to 62 days, with
quartiles of 3 and 7 days).
Additional complications, which occurred with the same frequency
as each other, were vomiting resulting in regurgitation of the tube
(7/89, 7.9%) and tube blockage whether it was resolved or not (7/89,
7.9%). Of the 7 cats recorded as having a blockage; 5 had tube size
information available, 3 recorded as 19Fr, 1 as 14Fr and 1 as 12Fr.
Seven cats had “vomited e-tube” recorded as a complication, of these
only 1 had tube size available, which was 12Fr. Nineteen cats had
“dislodged” recorded as a complication; of these, 8 had no e-tube size
recorded, of those with e-tube size recorded, 4 were 19Fr, 1 16Fr and
6 14Fr. There were also complications that occurred in individual cats,
including temporary laryngeal paralysis, focal esophageal rupture, irri-
tation of the tube site despite grossly-normal appearance of the
stoma, displacement of the tube causing a pharyngeal obstruction,
inflamed stoma in the absence of infection, dry discharge at the tube
site in the absence of infection, mucoid discharge surrounding the
tube, sterile necrosis surrounding the stoma site, and vomiting follow-
ing tube placement.
3.3 | Antimicrobials
Antimicrobial drugs were given to 167 cats, while their e-tubes were
in place; 85 started receiving them prior to tube placement and
82 started them after placement. The remaining 81 cats did not
receive antibiotics, while their e-tubes were in place, although 23 of
these cats had received antibiotics prior to tube placement. A single
antibiotic was given to 121 cats, while 31 cats received 2, 14 cats
received 3, and 1 cat received 4 antibiotics. The antibiotic drugs
prescribed, their combinations, and the frequency of each are
available in the supplementary materials. The cat that received
4 antibiotics was given a combination, although not concurrently,
of amoxicillin-clavulanate, clindamycin, marbofloxacin, and trimeth-
oprim sulphonamide.
TABLE 1 The underlying diseases that necessitated esophageal
feeding tube placement. Several of these categories are expanded
upon in the main manuscript
Disease category Number Percentage
Traumatic 40 16.1
Neoplastic 40 16.1
Pancreatic 35 14.1
Other 29 11.7
Gastrointestinal 28 11.3
Hepatopathy 23 9.3
Urogenital 17 6.9
Infectious 15 6.0
Septic 12 4.8
Respiratory 9 3.6
Total 248 100
“Other” stands for those in which the final diagnosis did not fall into any
of the other categories, or in those cases where a diagnosis was not
reached.
TABLE 2 The complication types encountered in the study
population. Those complications comprising the “Other” category are
detailed further in the manuscript
Complication type Number Percentage
None 159 64.1
Stoma site infection 30 12.1
Removed by cat 17 6.9
Dislodged by cat, removed 11 4.4
Other 9 3.6
Dislodged by cat, resutured 8 3.2
Tube vomited out 7 2.8
Tube blockage 7 2.8
Total 248 100
“Other” stands for those in which the final diagnosis did not fall into any
of the other categories, or in those cases where a diagnosis was not
reached.
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An infection was documented after the placement of an esopha-
geal e-tube in 30 cats, 19 of these had a culture performed, of which
1 recorded no growth and was instead diagnosed based on a combi-
nation of cytology and a failure to resolve spontaneously. Culture
identified only 1 organism in 12 cases: Escherichia coli (n = 5), Strep-
tococcus canis or Beta hemolytic Streptococci (n= 2), Pasteurella multocida
(n=2), Enterococcus spp. (n=1), Staphylococcus spp. (n= 1), and Pseudo-
monas aeruginosa (n =1). Three cats had 2 organisms isolated: E. coli with
Enterococcus spp. (n=2), and Pasteurella multocida with Staphylococcus
aureus (n = 1). Two cats had 3 organisms identified; Streptococcus
zooepidemicus, Enterococcus spp. and E. coli; and Candida spp., Entero-
coccus spp. and E. coli. The remaining cat had 4 organisms cultured;
methicillin resistant Staphylococcus pseudintermedius, E. coli, Pasteurella
multocida and Pasteurella pneumotropica. The resistance patterns of
these isolates are listed in Appendix 1. Of the 30 cats with an infection,
22 received antibiotics, 8 prior to tube placement, and 14 afterward
TABLE 3 Univariate analysis of association of variables with stoma site infection
Variable N B SE Wald df Sig OR
Lower
95% OR
Upper
95% OR
Age 248 0.004 0.004 0.97 1 0.33 1.00 0.99 1.01
Weight 237 −0.10 0.17 0.35 1 0.55 0.90 0.65 1.26
Institution 248 0.37 0.43 0.72 1 0.40 1.44 0.62 3.34
Systemic infection 248 −19.36 7463.65 0.000 1 0.99 0.00 0.00
Systemic inflammation 248 −0.25 0.40 0.39 1 0.53 0.78 0.35 1.71
Glucocorticoid or oncolytic administration 248 0.72 0.41 3.03 1 0.082 2.05 0.91 4.60
BCS 108 3.52 8 0.90
Death 248 −2.17 0.75 8.5 1 0.004 0.11 0.03 0.49
ABs with tube 248 0.33 0.44 0.55 1 0.46 1.38 0.59 3.26
Prior ABs 248 −0.18 0.40 0.19 1 0.66 0.84 0.38 1.84
Days in place 248 0.01 0.01 0.33 1 0.57 1.01 0.98 1.03
Home with tube 0.26 0.39 0.44 1 0.51 1.3 0.60 2.78
Class of disease 248 1.744 9 0.99
Discharge at e-tube site 248 4.71 1.03 20.91 1 0.000 112 14.8 841
Type of e-tube: 248 7.125 4 0.13
Baseline is “type not recorded” 83 1
SurgiVet 75 0.392 0.531 0.545 1 0.46 1.48 0.52 4.19
Mila 54 1.132 0.513 4.870 1 0.027 22 222 1.14 8.48
Cook 20 −0.560 1.099 0.259 1 0.61 0.57 0.066 4.93
Portex 16 −0.323 1.106 0.085 1 0.77 0.72 0.083 6.32
Size of e-tube 152 0.90 5 0.97
Abbreviations: Abs, antimicrobials; B, B statistic; BCS, body condition score; Df, degrees of freedom; N, number; OR, odds ratio; SE, standard error; Sig,
significance; Wald, Wald statistic.
TABLE 4 Multivariate analysis of association of variables with stoma site infection
B S.E. Wald df Sig. OR
Lower
95% CI
Upper
95% CI
Glucocorticoids or chemotherapy agents used? 1.36 0.63 4.68 1 0.031 3.9 1.14 13.44
Died −1.7 0.86 3.86 1 0.050 0.18 0.03 0.99
E-tube site discharge? 5.07 1.09 21.7 1 0.000 159.79 18.90 1351
E-tube type 10.90 4 0.028
Baseline is “type not recorded” 1
SurgiVet −0.93 0.69 1.85 1 0.17 0.39 0.10 1.51
Mila 1.51 0.75 4.10 1 0.043 4.51 1.05 19.4
Cook −0.69 1.37 0.25 1 0.62 0.50 0.04 7.3
Portex 1.14 1.51 0.58 1 0.45 3.14 0.16 60
Abbreviations: Abs, antimicrobials; B, B statistic; BCS, body condition score; Df, degrees of freedom; N, number; OR, odds ratio; SE, standard error; Sig,
significance; Wald, Wald statistic.
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(but were being administered at the time the infection was identified).
The remaining 8 did not receive antibiotics systemically and the stoma
site infections were managed topically.
Univariate binary logistic regression for stoma site infections iden-
tified that the use of glucocorticoids and chemotherapy agents, pres-
ence of a discharge at the stoma site, whether the cat died, and the
tube manufacturer as potential explanatory variables for infection.
These were taken forward to the multivariable analysis (Table 3). Mul-
tivariable logistic regression showed cats with a discharge at the
stoma site (OR=159.79, lower 95% OR 18.9, upper 95% OR 1351),
Mila feeding tubes (OR=4.51, lower 95% OR 1.05, upper 95% OR
19.4), and those receiving glucocorticoids or chemotherapy agents
(OR=3.9, lower 95% OR 1.14, upper 95% OR 13.44) had an increased
odds of developing a clinically relevant infection necessitating
TABLE 5 Univariate analysis of association of variables with death
Variable N B SE Wald df Sig OR
Lower
95% OR
Upper
95% OR
Age 248 0.006 0.003 5.28 1 0.022 1.01 1.001 1.011
Weight 237 −0.34 0.13 7.35 1 0.007 0.71 0.56 0.91
Institution 248 0.15 0.31 0.23 1 0.63 1.16 0.63 2.13
Systemic infection 248 −0.01 0.42 0.001 1 0.98 0.99 0.44 2.24
Systemic inflammation 248 0.50 0.27 3.49 1 0.062 1.66 0.98 2.81
Glucocorticoids or oncolytic agents used 248 0.15 0.31 0.23 1 0.63 1.16 0.63 2.13
Body condition score 108 4.9 8 0.77
Disease category (baseline = primary GI) 28 29.35 9 0.001 1
Hepatopathy 23 1.08 0.77 1.94 1 0.16 2.94 0.65 13.40
Pancreas 35 1.59 0.70 5.13 1 0.024 4.92 1.24 19.57
Trauma 40 0.73 0.73 1.02 1 0.31 2.08 0.50 8.67
Other 29 1.16 0.74 2.44 1 0.12 3.18 0.75 13.51
Neoplastic 40 2.74 0.7 15.53 1 0.000 15.48 3.96 60.45
Respiratory 9 2.34 0.91 6.67 1 0.010 10.42 1.76 61.67
Urogenital 17 1.51 0.79 3.63 1 0.057 4.55 0.96 21.56
Septic 12 1.02 0.90 1.28 1 0.26 2.78 0.47 16.35
Infectious 15 2.25 0.80 7.92 1 0.005 9.52 1.98 45.75
TABLE 6 Multivariate analysis of association of variables with death
B SE Wald df Sig OR
95% CI for OR
Lower Upper
Weight (kg) −0.29 0.14 4.53 1 0.033 0.75 0.57 0.98
Institution (A) 0.49 0.37 1.78 1 0.18 1.63 0.8 3.33
Age (months) 0.003 0.003 0.76 1 0.38 1.003 0.99 1.10
Disease category
Compared to primary GI 26.13 9 0.002 1
Hepatopathy 1.14 0.79 2.07 1 0.15 3.11 0.66 14.62
Pancreas 1.47 0.74 3.92 1 0.048 4.33 1.02 18.47
Trauma 0.71 0.80 0.78 1 0.38 2.03 0.42 9.74
Other 1.43 0.77 3.44 1 0.064 4.17 0.92 18.89
Neoplastic 2.74 0.73 13.92 1 0.000 15.44 3.67 65.07
Respiratory 2.98 0.99 9.01 1 0.003 19.66 2.81 137.48
Urogenital 1.75 0.82 4.54 1 0.033 5.78 1.15 28.99
Septic 1.25 0.92 1.82 1 0.18 3.48 0.57 21.28
Infectious 2.45 0.83 8.68 1 0.003 11.57 2.27 58.94
Abbreviations: Abs, antimicrobials; B, B statistic; BCS, body condition score; Df, degrees of freedom; N, number; OR, odds ratio; SE, standard error; Sig,
significance; Wald, Wald statistic.
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treatment. Cats that died had a decreased odds of developing an infec-
tion requiring treatment (OR=0.18, lower 95% OR 0.03, upper 95%
OR 0.99). This is summarized in Table 4. There were no interactions
between variables in the final model and no problems with collinearity.
Univariate binary logistic regression for death highlighted older
age, decreased weight, disease category, and the presence of systemic
inflammation as potential explanatory variables. These variables
were then taken forward to the multivariable analysis (Table 5). Also
included within the multivariate analysis was the institution the case
was managed at as this was a potential confounding variable. The final
multivariate model (summarized in Table 6) showed that death was
influenced by cat weight (OR= 1.33 for lower weight, lower 95% OR
0.57, upper 95% OR 0.98), and respiratory (OR=19.66, lower 95%
OR 2.81, upper 95% OR 137.5), neoplastic (OR=15.44, lower 95% OR
3.67, upper 95% OR 65.07), infectious (OR=11.57, lower 95% OR
2.27, upper 95% OR 59.9), urogenital (OR=5.78, lower 95% OR 1.15,
upper 95% OR 29), and pancreatic (OR=4.33, lower 95% OR 1.02,
upper 95% OR 18.5) diseases. Age did not have a significant effect,
but its inclusion improved the model, and there are clear a priori rea-
sons for its inclusion. There were no interactions between variables in
the final model and no problems with collinearity.
4 | DISCUSSION
This large-scale study investigates the placement of e-tubes in compan-
ion animal medicine, alongside the consequences, their predisposing
factors, and outcomes of having these tubes in place. The median time
from hospitalization to e-tube placement was 1 day. This is appropriate
given that nutritional support of anorexic cats should be commenced
within 3 days of anorexia, or moderate hyporexia, to minimize the risk
of secondary hepatic lipidosis.1 However, the current study did reveal
that having an e-tube in place is not entirely benign, as it carried a com-
plication rate of 35.8%, increasing to 48% in the cats that survived to
discharge. The most frequent complication was tube dislodgement,
followed by a clinically stoma site infection. Other problems ranged in
severity from tube obstruction, and temporary laryngeal paralysis to
focal esophageal rupture. No cats in this study died from or suffered
from severe morbidity related to the tube that was not remedied by its
removal. Previous studies have assessed the relative merits and compli-
cations of different types of feeding tube. Naso-gastric13 and endoscop-
ically placed low profile gastrostomy tubes in dogs and cats14 have
complication rates of 37% and 62.5%, respectively, compared to a com-
plication rate of 71% in cats with e-tubes in a previous study.11 The rea-
sons for the discrepancy between the latter study and the current 1 are
unclear, but could include different clinic populations, or improvements
in e-tube materials, placement techniques, and aftercare in the last
15years.
Stoma site infection was the second most commonly encountered
complication, occurring in 12.1% of cases. Organisms associated with
stoma site infections can originate from the skin, oral cavity, gastroin-
testinal tract, in-contact animals and humans, or, potentially, the envi-
ronment. Most of the infections in this study involved commensal
organisms rather than primary pathogens or environmental organisms.
E. coli and Enterococcus spp. were the 2 most commonly isolated
bacteria; together they comprised 13 of the 28 (46.4%) bacteria iso-
lated. These are normal commensals of the gastrointestinal tract.15,16
Pasteurella species were isolated in 3 of the cases (10.7%). Pasteurella
spp. are common commensals of the feline oral cavity and respiratory
tract,17 with 1 study identifying them in 90% of feline gingival mar-
gins.17 Streptococcus canis is also a natural commensal of the canine
and feline respiratory tract,18 and a variety of staphylococcal species
can be isolated from skin and mucocutaneous sites.19
There are several ways bacteria can contaminate stoma sites.
Direct contact could occur when cats adopt a natural sleeping posi-
tion, curled up with their head close to their perineum. This presents
an opportunity for perineal fecal contamination (either gross or micro-
scopic) to contact the stoma site or dressings. Such contamination
could be facilitated by poor stoma site hygiene, prolonged duration
between bandage changes, and can be complicated by conditions,
which result in altered fecal consistency.
An additional source of infection is esophageal contents. Strepto-
coccus spp. are isolated in 98-99% cases of esophageal cultures in
humans, with other pathogens being isolated with individual variation
including Fusobacterium spp., Neisseria spp., Hemophiluus spp., and
Prevotella spp20. Currently, there is not comparable data on the normal
flora of the feline esophagus, making it difficult to determine if bacte-
ria originate from the esophagus or from elsewhere. The upper gastro-
intestinal tract remains patent when an e-tube is in place, and bacteria
can still be ingested when the cats groom themselves (as evidenced
by 1 of the tubes becoming blocked by hair), or through ingestion of
food or prey. In addition, swallowed oral secretions and, potentially,
refluxed gastrointestinal contents could contaminate the stoma inter-
nally. This, in those cats where immunocompetence was inadequate,
could then progress to an infection. This could influence local flora,
with selection pressures allowing certain bacteria to grow unopposed.
Bacteria from the gastrointestinal tract of prey species cannot be
ruled out as potential source of infection, although this is less likely as
cats with e-tubes are often too ill to be hunting or are usually kept
indoors.
It is clear that e-tubes predispose to infections with opportunistic
bacteria. Importantly, the normal anatomical protective mechanisms
of the skin are bypassed once the tube is in place. It also creates a
connection between 2 populations of flora that are naturally sepa-
rated, altering interactions and potentially allowing overgrowth of cer-
tain populations. The e-tube itself will cause local tissue irritation,
precipitated by chronic micro-movements and foreign body reaction
despite the tubing material being relatively inert. Self-trauma, second-
ary to discomfort or irritation, could cause secondary wounds or dam-
age to the tube, gross or microscopic, allowing bacteria to colonize
more readily and potentially form antibiotic-resistant biofilms.21 In
addition, it is likely that immunosuppression secondary to underlying
disease might play a role in the development of infection.22 Adminis-
tration of glucocorticoids or chemotherapeutic medications was asso-
ciated with an increased odds of developing a stoma site infection.
This is not an unexpected finding with a higher rate and severity of
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complications previously reported in veterinary cats receiving prednis-
olone at the time of percutaneous gastrostomy tube placement.23 The
current study supports the concept that owners and the veterinary
health care team should be aware of the potentially increased risk of
stoma site infection if the cats are receiving glucocorticoids or chemo-
therapy agents, and that the importance of appropriate stoma site
hygiene should be stressed.
In this study, the information available in the multivariate model
showed that Mila tubes were associated with a higher odds of devel-
oping an infection, suggesting that it might be prudent to use e-tubes
made from other materials. The gauge of the tube did not influence
the odds of infection, potentially suggesting that the widest gauge
possible should be used to facilitate ease of feeding and minimizing
the risk of blockage, that is, so long as it is not so large as to cause dis-
comfort. However, these findings should be interpreted with caution
as the tube manufacturer was only available for a subset (n = 165) of
the cats, and 83 of the cats (33.4%) did not have the tube type or size
recorded.
Cats that died were at a lower risk of e-tube complications,
including stoma site infection. Cats died a median of 4 days after
presentation to the referral center, whereas the median time to
stoma site discharge and infection occurred at day 6. The most likely
explanation for these findings is that the cats that died due to their
underlying condition did so before there was time to acquire an
e-tube infection. One cat developed subcutaneous emphysema sec-
ondary to focal esophageal rupture, at a site separate from the intuba-
tion site. This cat presented with a megaesophagus and was diagnosed
with dysautonomia on histopathology, and esophageal ulceration was
noted on gross pathology. The site of focal rupture was 5 cm distal to
the intubation site and was not believed to be related to the tube
placement.
The length of time that the tube was in place, whether the cat was
discharged home with the tube still in place, and the underlying dis-
ease process were not associated with an increased odds of infection.
This suggests that when appropriate care is taken of the stoma site,
these tubes can be left in for long periods of time and managed at
home by owners, without expecting an increase in stoma site infec-
tions. While the median time the tubes were in place were 11 days,
1 case it was in place for 94 days, so protracted periods of e-tube
placement was assessed. This information can be useful in assisting
owners with informed decision making as to whether they would like
to proceed with e-placement, taking into account the stoma site care
involved, and likely duration.
In the multivariate model, the main factors associated with death
were body weight and certain disease processes. Those with a lower
body weight had an increased odds ratio of dying of their disease.
Lower body weight has been previously shown to be associated with
a poorer prognosis in a number of conditions.24–26 Unfortunately, the
BCS was not available for a large number of the cats in the current
study, so it is difficult to identify whether it was the thinner cats that
had the poorer prognosis or just those with a smaller stature. The
explanation for why certain disease processes were associated with a
poorer prognosis is less apparent. As with all veterinary studies
concerning survival, a major confounding factor is the role of the
owner and their wishes for when euthanasia is performed. Cats with
traumatic and septic illness necessitating e-tube placement incurred a
more favorable prognosis; part of this might be that the owners were
aware of the underlying disease process at the time of e-tube place-
ment and were invested in continuing in the knowledge of the prog-
nosis and required management intensity. With the other conditions,
it might be that euthanasia occurred as a result of certain diagnoses
with a genuine or perceived poor prognosis, although this is purely
speculative.
There are a number of limitations to this study. The main limita-
tion was the retrospective nature of the data. As the data were col-
lated over a 12-year period, there will have been variation in the
personnel involved in each institution, as well as a lack of a stan-
dardized approach to tube placement. There is also the inherent lack
of standardized record keeping, which can result in incomplete or
inconsistent record keeping. In addition, there might have been
minor complications that were not considered concerning enough
to document, or if any stoma-site discharges were self-limiting. This
could have resulted in an artificially low complication rate. Another
difficulty was that the anorexia necessitating tube placement was
usually secondary to an underlying medical condition, which might
have required different management strategies or antimicrobial
therapy. Antimicrobial use will have varied over the study timescale.
Additionally, it was not possible to garner from the clinical records
the frequency and method of stoma site maintenance and dressing,
which might have had an impact. A prospective study would be
required to determine the risk factors for stoma site infections in
more detail. This would allow a standardized protocol for tube
placement and post-operative management, as well as the selection
of cases with a common disease process of similar severity. The
results from such a study would help inform evidence-based recom-
mendations for management strategies and antimicrobial use with
e-tubes. Additionally, the current study was conducted over 2 refer-
ral centers, with considerable experience in the placement and
maintenance of these tubes. Complications rates and associated
morbidity might be higher in those practices in which these are
rarely placed.
In conclusion, e-tubes remain a crucial part of providing a cat's
nutritional demands, although they are not without potential compli-
cations. They are relatively easily placed with few complications
incurred at the time of placement, provided tube placement is con-
firmed both visually and radiographically or endoscopically prior to
anesthetic recovery. While none of the cats in this study died as a
result of tube placement, incorrect placement or tube migration could
result in death. The tubes are generally well tolerated, with only a rela-
tively small proportion being removed by the cat prematurely. The
tubes were in place for a median of 11 days, with the longest duration
of 94 days, without an increased odds of complications. Stoma site
infection is a relatively frequent complication and should be discussed
with the owners prior to placement, particularly when there are addi-
tional predisposing factors such as receiving systemic glucocorticoids
or chemotherapy agents.
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